-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Financial Contrast: Zenvia (NASDAQ:ZENV) & Definitive Healthcare (NASDAQ:DH)
Financial Contrast: Zenvia (NASDAQ:ZENV) & Definitive Healthcare (NASDAQ:DH)
Definitive Healthcare (NASDAQ:DH – Get Rating) and Zenvia (NASDAQ:ZENV – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.
Analyst Recommendations
This is a summary of current ratings and price targets for Definitive Healthcare and Zenvia, as provided by MarketBeat.
Get Definitive Healthcare alerts:| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Definitive Healthcare | 0 | 5 | 4 | 0 | 2.44 |
| Zenvia | 0 | 4 | 0 | 0 | 2.00 |
Definitive Healthcare presently has a consensus target price of $19.11, indicating a potential upside of 73.90%. Zenvia has a consensus target price of $2.63, indicating a potential upside of 128.26%. Given Zenvia's higher probable upside, analysts plainly believe Zenvia is more favorable than Definitive Healthcare.
Valuation & Earnings
This table compares Definitive Healthcare and Zenvia's top-line revenue, earnings per share (EPS) and valuation.| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Definitive Healthcare | $166.15 million | 6.95 | -$51.02 million | ($0.27) | -40.70 |
| Zenvia | $113.49 million | 0.42 | -$8.27 million | ($0.25) | -4.60 |
Zenvia has lower revenue, but higher earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Zenvia, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
35.7% of Zenvia shares are owned by institutional investors. 17.5% of Definitive Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Definitive Healthcare and Zenvia's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Definitive Healthcare | -12.56% | 0.69% | 0.49% |
| Zenvia | -5.59% | -3.71% | -2.36% |
Risk & Volatility
Definitive Healthcare has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500. Comparatively, Zenvia has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.
About Definitive Healthcare
(Get Rating)
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
About Zenvia
(Get Rating)
Zenvia Inc. provides customer experience communications platform which empowers businesses to create unique journeys for their end-customers along their life cycle across range of B2C verticals. Zenvia Inc. is based in S?O PAULO.
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
Definitive Healthcare (NASDAQ:DH – Get Rating) and Zenvia (NASDAQ:ZENV – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.
確定醫療(納斯達克：HD-GET評級)和捷維亞(納斯達克：ZENV-GET評級)都是小盤醫療公司，但哪一項業務更優越？我們將根據這兩家公司的估值、盈利能力、股息、分析師建議、收益、機構所有權和風險等方面的實力進行對比。
Analyst Recommendations
分析師建議
This is a summary of current ratings and price targets for Definitive Healthcare and Zenvia, as provided by MarketBeat.
這是由MarketBeat提供的最終醫療保健和Zenvia的當前評級和目標價的摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Definitive Healthcare | 0 | 5 | 4 | 0 | 2.44 |
| Zenvia | 0 | 4 | 0 | 0 | 2.00 |
| 銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
| 權威醫療保健 | 0 | 5 | 4 | 0 | 2.44 |
| Zenvia | 0 | 4 | 0 | 0 | 2.00 |
Definitive Healthcare presently has a consensus target price of $19.11, indicating a potential upside of 73.90%. Zenvia has a consensus target price of $2.63, indicating a potential upside of 128.26%. Given Zenvia's higher probable upside, analysts plainly believe Zenvia is more favorable than Definitive Healthcare.
Finitive Healthcare目前的共識目標價為19.11美元，表明潛在上行空間為73.90%。Zenvia的一致目標價為2.63美元，表明潛在上漲128.26%。考慮到Zenvia更有可能的上行空間，分析師們顯然認為Zenvia比Defintive Healthcare更有利。
Valuation & Earnings
估值與收益
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Definitive Healthcare | $166.15 million | 6.95 | -$51.02 million | ($0.27) | -40.70 |
| Zenvia | $113.49 million | 0.42 | -$8.27 million | ($0.25) | -4.60 |
| 總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 市盈率 | |
| 權威醫療保健 | 1.6615億美元 | 6.95 | -5,102萬元 | ($0.27) | -40.70 |
| Zenvia | 1.1349億美元 | 0.42 | -827萬元 | ($0.25) | -4.60 |
Zenvia has lower revenue, but higher earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Zenvia, indicating that it is currently the more affordable of the two stocks.
與Defintive Healthcare相比，Zenvia的收入較低，但收益較高。最終醫療保健的市盈率低於Zenvia，這表明它目前是兩隻股票中更負擔得起的一隻。
Insider and Institutional Ownership
內部人與機構持股
35.7% of Zenvia shares are owned by institutional investors. 17.5% of Definitive Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Zenvia 35.7%的股份由機構投資者持有。最終醫療保健公司17.5%的股份由公司內部人士持有。強大的機構持股表明，對衝基金、捐贈基金和大型基金經理相信，從長期來看，一隻股票的表現將好於大盤。
Profitability
盈利能力
This table compares Definitive Healthcare and Zenvia's net margins, return on equity and return on assets.
此表比較了Desitive Healthcare和Zenvia的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Definitive Healthcare | -12.56% | 0.69% | 0.49% |
| Zenvia | -5.59% | -3.71% | -2.36% |
| 淨利潤率 | 股本回報率 | 資產回報率 | |
| 權威醫療保健 | -12.56% | 0.69% | 0.49% |
| Zenvia | -5.59% | -3.71% | -2.36% |
Risk & Volatility
風險與波動性
Definitive Healthcare has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500. Comparatively, Zenvia has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.
Finitive Healthcare的貝塔係數為0.4，表明其股價的波動性比標準普爾500指數低60%。相比之下，Zenvia的貝塔係數為1.56，這表明其股價的波動性比標準普爾500指數高56%。
About Definitive Healthcare
關於終極醫療保健
(Get Rating)
(獲取評級)
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Finitive Healthcare Corp.及其子公司在美國提供醫療保健商業情報。其解決方案提供有關醫療保健提供者及其活動的信息，以幫助該領域的客户，範圍從產品開發到上市規劃，以及銷售和營銷執行。該公司的平臺提供16個智能模塊，涵蓋銷售、營銷、臨牀研究和產品開發、戰略、人才獲取和醫生網絡管理等功能領域。它為生物製藥和醫療器械公司、醫療保健信息技術公司和醫療保健提供者提供服務；以及其他多元化公司，包括醫療保健生態系統中的人員和商業房地產公司、金融機構和其他組織。Finitive Healthcare Corp.成立於2011年，總部設在馬薩諸塞州弗雷明翰。
About Zenvia
關於Zenvia
(Get Rating)
(獲取評級)
Zenvia Inc. provides customer experience communications platform which empowers businesses to create unique journeys for their end-customers along their life cycle across range of B2C verticals. Zenvia Inc. is based in S?O PAULO.
Zenvia Inc.提供客户體驗交流平臺，使企業能夠為其最終客户在其生命週期中跨越一系列B2C垂直市場創造獨特的旅程。Zenvia Inc.的總部設在聖保羅。
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
獲得權威醫療日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收最新新聞和分析師對最終醫療保健及相關公司的評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧